Advertisement
Advertisement

IRD

IRD logo

Opus Genetics, Inc. Common Stock

3.31
USD
Sponsored
+0.23
+7.31%
Jul 27, 14:17 UTC -4
Open

Opus Genetics, Inc. Common Stock Profile

About

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.

Info & Links

CEO

George Magrath

Headquarters

8 Davis Drive, Suite 220
Durham, NC 27713, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://opusgtx.com

Auditor

Ernst & Young LLP

Share holders

64

Employees

28

Opus Genetics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

272.88M

Enterprise Value

212.92M

Enterprise Value/EBITDA(ttm)

-4.95

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

27.57

Price to Book(mrq)

24.71

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-261.76%

Profit Margin(ttm)

-359.84%

Return on Equity(ttm)

-338.88%

Return on Invested Capital(ttm)

-557.45%

Return on Assets(ttm)

-85.82%

Income Statement

Revenue(ttm)

11.98M

Revenue Per Share(ttm)

0.15

Gross Profit(ttm)

11.98M

EBITDA(ttm)3

-42.98M

Net Income Available to Common(ttm)

-106.93M

Diluted EPS(ttm)

-0.82

Share Statistics

Beta (5Y Monthly)

0.52

52-Week Change

180.08%

S&P 500 52-Week Change

15.81%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

81.40M

Dividend Yield

0.00%

Float4

62.83M

% Held by Insiders

11.70%

% Held by Institutions

14.97%

Balance Sheet

Total Cash(mrq)

59.96M

Total Cash Per Share(mrq)

0.74

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.43%

Quick Ratio(mrq)

6.43%

Book Value Per Share(mrq)

0.22

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.57

Free Cash Flow(ytd)

-35.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement